SEARCH

SEARCH BY CITATION

References

  • BÁTKAI, S., JÁRAI, Z., WAGNER, J.A., GOPARAJU, S.K., VARGA, K., LIU, J., WANG, L., MIRSHAHI, F., KHANOLKAR, A.D., MAKRIYANNIS, A., URBASCHEK, R., GARCIA JR, N., SANYAL, A.J. & KUNOS, G. (2001). Endocannabinoids acting at vascular CB1 receptors mediate the vasodilated state in advanced liver cirrhosis. Nat. Med., 7, 827832.
  • BÁTKAI, S., PACHER, P., OSEI-HYIAMAN, D., RADAEVA, S., LIU, J., HARVEY-WHITE, J., OFFERTÁLER, L., MACKIE, K., RUDD, M.A., BUKOSKI, R.D. & KUNOS, G. (2004). Endocannabinoids acting at cannabinoid-1 receptors regulate cardiovascular function in hypertension. Circulation, 110, 19962002.
  • BONZ, A., LASER, M., KULLMER, S., KNIESCH, S., BABIN-EBELL, J., POPP, V., ERTL, G. & WAGNER, J.A. (2003). Cannabinoids acting on CB1 receptors decrease contractile performance in human atrial muscle. J. Cardiovasc. Pharmacol., 41, 657664.
  • DI MARZO, V., BISOGNO, T., DE PETROCELLIS, L., MELCK, D., ORLANDO, P., WAGNER, J.A. & KUNOS, G. (1999). Biosynthesis and inactivation of the endocannabinoid 2-arachidonoylglycerol in circulating and tumoral macrophages. Eur. J. Biochem., 264, 258267.
  • DOMENICALI, M., ROS, J., FERNANDEZ-VARO, G., CEJUDO-MARTIN, P., CRESPO, M., MORALES-RUIZ, M., BRIONES, A.M., CAMPISTOL, J.M., ARROYO, V., VILA, E., RODES, J. & JIMENEZ, W. (2005). Increased anandamide induced relaxation in mesenteric arteries of cirrhotic rats: role of cannabinoid and vanilloid receptors. Gut, 54, 522527.
  • GASKARI, S.A., LIU, H., MOEZI, L., LI, Y., BAIK, S.K. & LEE, S.S. (2005). Role of endocannabinoids in the pathogenesis of cirrhotic cardiomyopathy in bile duct-ligated rats. Br. J. Pharmacol., 146, 315323.(this issue).
  • GINES, P., QUINTERO, E., ARROYO, V., TERES, J., BRUGUERA, M., RIMOLA, A., CABALLERIA, J., RODES, J. & ROZMAN, C. (1987). Compensated cirrhosis: natural history and prognostic factors. Hepatology, 7, 122128.
  • GRENARD, P., JULIEN, B., TRAN VAN NHIEU, J., LI, L., LEDENT, C., MALLAT, A. & LOTERSZTAJN, S. (2004). Reduced fibrosis in mice invalidated for CB1 receptor. 2004 Symposium on the Cannabinoids. Burlington, Vermont, International Cannabinoid Research Society, p 60.
  • LIU, J., BÁTKAI, S., PACHER, P., HARVEY-WHITE, J., WAGNER, J.A., CRAVATT, B.F., GAO, B. & KUNOS, G. (2003). Lipopolysaccharide induces anandamide synthesis in macrophages via CD14/MAPK/phosphoinositide 3-kinase/NF-kappaB independently of platelet-activating factor. J. Biol. Chem., 278, 4503445039.
  • MA, Z. & LEE, S.S. (1996). Cirrhotic cardiomyopathy: getting to the heart of the matter. Hepatology, 24, 451459.
  • MOLLER, S. & HENRIKSEN, J.H. (2002). Cirrhotic cardiomyopathy: a pathophysiological review of circulatory dysfunction in liver disease. Heart, 87, 915.
  • PACHER, P., BÁTKAI, S. & KUNOS, G. (2005). Blood pressure regulation by endocannabinoids and their receptors. Neuropharmacology, 48, 11301138.
  • ROS, J., CLARIA, J., TO-FIGUERAS, J., PLANAGUMA, A., CEJUDO-MARTIN, P., FERNANDEZ-VARO, G., MARTIN-RUIZ, R., ARROYO, V., RIVERA, F., RODES, J. & JIMENEZ, W. (2002). Endogenous cannabinoids: a new system involved in the homeostasis of arterial pressure in experimental cirrhosis in the rat. Gastroenterology, 122, 8593.